| UniProt ID | CACB4_HUMAN | |
|---|---|---|
| UniProt AC | O00305 | |
| Protein Name | Voltage-dependent L-type calcium channel subunit beta-4 {ECO:0000305} | |
| Gene Name | CACNB4 {ECO:0000312|HGNC:HGNC:1404} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 520 | |
| Subcellular Localization | ||
| Protein Description | The beta subunit of voltage-dependent calcium channels contributes to the function of the calcium channel by increasing peak calcium current, shifting the voltage dependencies of activation and inactivation, modulating G protein inhibition and controlling the alpha-1 subunit membrane targeting.. | |
| Protein Sequence | MSSSSYAKNGTADGPHSPTSQVARGTTTRRSRLKRSDGSTTSTSFILRQGSADSYTSRPSDSDVSLEEDREAIRQEREQQAAIQLERAKSKPVAFAVKTNVSYCGALDEDVPVPSTAISFDAKDFLHIKEKYNNDWWIGRLVKEGCEIGFIPSPLRLENIRIQQEQKRGRFHGGKSSGNSSSSLGEMVSGTFRATPTSTAKQKQKVTEHIPPYDVVPSMRPVVLVGPSLKGYEVTDMMQKALFDFLKHRFDGRISITRVTADISLAKRSVLNNPSKRAIIERSNTRSSLAEVQSEIERIFELARSLQLVVLDADTINHPAQLIKTSLAPIIVHVKVSSPKVLQRLIKSRGKSQSKHLNVQLVAADKLAQCPPEMFDVILDENQLEDACEHLGEYLEAYWRATHTTSSTPMTPLLGRNLGSTALSPYPTAISGLQSQRMRHSNHSTENSPIERRSLMTSDENYHNERARKSRNRLSSSSQHSRDHYPLVEEDYPDSYQDTYKPHRNRGSPGGYSHDSRHRL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSSSSYAKN ------CCCHHCCCC | 38.64 | 22210691 | |
| 3 | Phosphorylation | -----MSSSSYAKNG -----CCCHHCCCCC | 23.23 | 22210691 | |
| 11 | Phosphorylation | SSYAKNGTADGPHSP HHCCCCCCCCCCCCC | 30.85 | - | |
| 13 (in isoform 2) | Phosphorylation | - | 71.62 | 22210691 | |
| 21 (in isoform 2) | Phosphorylation | - | 35.05 | 22210691 | |
| 39 | Phosphorylation | RLKRSDGSTTSTSFI HCCCCCCCCCCCEEE | 33.24 | - | |
| 51 | Phosphorylation | SFILRQGSADSYTSR EEEEECCCCCCCCCC | 22.14 | 23312004 | |
| 54 | Phosphorylation | LRQGSADSYTSRPSD EECCCCCCCCCCCCC | 29.99 | 23312004 | |
| 55 | Phosphorylation | RQGSADSYTSRPSDS ECCCCCCCCCCCCCC | 14.85 | 23312004 | |
| 56 | Phosphorylation | QGSADSYTSRPSDSD CCCCCCCCCCCCCCC | 23.39 | 23312004 | |
| 57 | Phosphorylation | GSADSYTSRPSDSDV CCCCCCCCCCCCCCC | 33.68 | 23312004 | |
| 60 | Phosphorylation | DSYTSRPSDSDVSLE CCCCCCCCCCCCCHH | 48.95 | 23312004 | |
| 62 | Phosphorylation | YTSRPSDSDVSLEED CCCCCCCCCCCHHHH | 44.22 | 23312004 | |
| 65 | Phosphorylation | RPSDSDVSLEEDREA CCCCCCCCHHHHHHH | 34.75 | 23312004 | |
| 99 | Phosphorylation | PVAFAVKTNVSYCGA CEEEEEECCCCCCCC | 33.96 | 18220336 | |
| 102 | Phosphorylation | FAVKTNVSYCGALDE EEEECCCCCCCCCCC | 19.44 | 18220336 | |
| 103 | Phosphorylation | AVKTNVSYCGALDED EEECCCCCCCCCCCC | 7.22 | 18220336 | |
| 180 | Phosphorylation | GGKSSGNSSSSLGEM CCCCCCCCCCCHHHH | 34.81 | - | |
| 182 | Phosphorylation | KSSGNSSSSLGEMVS CCCCCCCCCHHHHHC | 29.42 | - | |
| 183 | Phosphorylation | SSGNSSSSLGEMVSG CCCCCCCCHHHHHCC | 42.20 | - | |
| 207 | Phosphorylation | AKQKQKVTEHIPPYD HHHHHHCCCCCCCCC | 28.96 | 24719451 | |
| 213 | Phosphorylation | VTEHIPPYDVVPSMR CCCCCCCCCCCCCCC | 18.93 | - | |
| 218 | Phosphorylation | PPYDVVPSMRPVVLV CCCCCCCCCCCEEEE | 18.80 | 24275569 | |
| 228 | Phosphorylation | PVVLVGPSLKGYEVT CEEEECCCCCCCCHH | 36.46 | 24275569 | |
| 232 | Phosphorylation | VGPSLKGYEVTDMMQ ECCCCCCCCHHHHHH | 12.97 | 24275569 | |
| 235 | Phosphorylation | SLKGYEVTDMMQKAL CCCCCCHHHHHHHHH | 13.26 | 24275569 | |
| 255 | Phosphorylation | HRFDGRISITRVTAD HHCCCCCEEEEEECC | 19.29 | 24719451 | |
| 257 | Phosphorylation | FDGRISITRVTADIS CCCCCEEEEEECCHH | 16.58 | 23312004 | |
| 260 | Phosphorylation | RISITRVTADISLAK CCEEEEEECCHHHHH | 18.47 | 23312004 | |
| 264 | Phosphorylation | TRVTADISLAKRSVL EEEECCHHHHHHHHH | 23.87 | 29083192 | |
| 276 | Acetylation | SVLNNPSKRAIIERS HHHCCHHHHHHHHCC | 47.29 | 21466224 | |
| 337 | Phosphorylation | IIVHVKVSSPKVLQR EEEEEECCCHHHHHH | 34.89 | 24719451 | |
| 411 | Phosphorylation | TTSSTPMTPLLGRNL CCCCCCCCCCCCCCC | 16.40 | 24076635 | |
| 421 | Phosphorylation | LGRNLGSTALSPYPT CCCCCCCCCCCCCCC | 29.80 | - | |
| 435 | Phosphorylation | TAISGLQSQRMRHSN CHHHHHHHHHHHCCC | 25.46 | - | |
| 448 | Phosphorylation | SNHSTENSPIERRSL CCCCCCCCHHHHHHC | 22.48 | - | |
| 476 | Phosphorylation | KSRNRLSSSSQHSRD HHHHHHCCCCCCCCC | 38.30 | 21712546 | |
| 477 | Phosphorylation | SRNRLSSSSQHSRDH HHHHHCCCCCCCCCC | 30.55 | 21712546 | |
| 481 | Phosphorylation | LSSSSQHSRDHYPLV HCCCCCCCCCCCCCC | 31.59 | 21712546 | |
| 499 | Phosphorylation | YPDSYQDTYKPHRNR CCCCCCCCCCCCCCC | 20.23 | - | |
| 500 | Phosphorylation | PDSYQDTYKPHRNRG CCCCCCCCCCCCCCC | 30.71 | - | |
| 506 | Methylation | TYKPHRNRGSPGGYS CCCCCCCCCCCCCCC | 47.09 | - | |
| 508 | Phosphorylation | KPHRNRGSPGGYSHD CCCCCCCCCCCCCCC | 19.68 | - | |
| 512 | Phosphorylation | NRGSPGGYSHDSRHR CCCCCCCCCCCCCCC | 14.56 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CACB4_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CACB4_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CACB4_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TBL3_HUMAN | TBL3 | physical | 16169070 | |
| MED31_HUMAN | MED31 | physical | 16169070 | |
| PTN_HUMAN | PTN | physical | 16169070 | |
| CAC1A_HUMAN | CACNA1A | physical | 10212211 | |
| CBX3_HUMAN | CBX3 | physical | 21220418 | |
| CACB3_HUMAN | CACNB3 | physical | 28514442 | |
| GT252_HUMAN | COLGALT2 | physical | 28514442 |
| Kegg Disease | |
|---|---|
| There are no disease associations of PTM sites. | |
| OMIM Disease | |
| 607682 | Epilepsy, idiopathic generalized 9 (EIG9) |
| 607682 | Juvenile myoclonic epilepsy 6 (EJM6) |
| 613855 | Episodic ataxia 5 (EA5) |
| Kegg Drug | |
| There are no disease associations of PTM sites. | |
| DrugBank | |
| DB04855 | Dronedarone |
| DB00393 | Nimodipine |
| DB00421 | Spironolactone |
| DB00661 | Verapamil |
loading...